Indolicidin is an antimicrobial peptide.1 It is active against multidrug-resistant isolates of enteroaggregative E. coli (MDR-EAEC; MICs = 32 µM for all). Indolicidin is also active against S. cerevisiae, T. beigelii, and C. albicans (MICs = 5-10, 2.5-5, and 5-10 µM, respectively) and reduces viral replication of HIV-1 in MT-2 cells when used at concentrations ranging from 67 to 100 µg/ml.2,3 In vivo, indolicidin increases survival of MDR-EAEC-infected G. mellonella larvae.1
1.Vergis, J., Malik, S.S., Pathak, R., et al.Antimicrobial efficacy of indolicidin against multi-drug resistant enteroaggregative Escherichia coli in a Galleria mellonella modelFront. Microbiol.102723(2019) 2.Lee, D.G., Kim, H.K., Kim, S.A., et al.Fungicidal effect of indolicidin and its interaction with phospholipid membranesBiochem. Biophys. Res. Commun.305(2)305-310(2003) 3.Robinson, W.E., Jr., McDougall, B., Tran, D., et al.Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophilsJ. Leukoc. Biol.63(1)94-100(1998)
















